Verkazia Alternatives Compared
Verkazia (cyclosporine) | Maxitrol (dexamethasone / neomycin / polymyxin b) | Diclofenac ophthalmic |
|
---|
Verkazia (cyclosporine) | Maxitrol (dexamethasone / neomycin / polymyxin b) | Diclofenac ophthalmic |
|
|||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for Keratoconjunctivitis. Verkazia may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Blepharitis, Conjunctivitis - Bacterial, Uveitis, Keratitis, Keratoconjunctivitis. Maxitrol may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Conjunctivitis, Corneal Ulcer, Postoperative Ocular Inflammation, Inhibition of Intraoperative Miosis, Keratoconjunctivitis. Diclofenac ophthalmic may also be used for purposes not... View more |
Related suggestions |
|||||||||||||||||||||||
More about Verkazia (cyclosporine) | More about Maxitrol (dexamethasone / neomycin / polymyxin b) | More about Diclofenac ophthalmic | ||||||||||||||||||||||||
Ratings & Reviews | ||||||||||||||||||||||||||
Be the first to share your experience with this drug. |
Maxitrol has an average rating of 10.0 out of 10 from a total of 2 ratings on Drugs.com. 100% of reviewers reported a positive effect, while 0% reported a negative effect. |
Diclofenac ophthalmic has an average rating of 6.3 out of 10 from a total of 3 ratings on Drugs.com. 33% of reviewers reported a positive effect, while 0% reported a negative effect. |
||||||||||||||||||||||||
Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | ||||||||||||||||||||||||||
View all Verkazia side effects |
View all Maxitrol side effects |
View all Diclofenac ophthalmic side effects |
||||||||||||||||||||||||
Drug Class | ||||||||||||||||||||||||||
Generic Availability | ||||||||||||||||||||||||||
Lower cost generic |
||||||||||||||||||||||||||
Pricing and Coupons * Prices are without insurance | ||||||||||||||||||||||||||
View all Verkazia prices |
View all Maxitrol prices |
View all Diclofenac ophthalmic prices |
||||||||||||||||||||||||
Dosage Forms | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
Brand Names | ||||||||||||||||||||||||||
Other cyclosporine brands include: Cequa, Restasis, Vevye | Other dexamethasone / neomycin / polymyxin b brands include: AK-Trol, Dexacine, Dexasporin, Neo-Poly-Dex, NPD Ophthalmic Ointment, Poly-Dex | Voltaren Ophthalmic | ||||||||||||||||||||||||
Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | ||||||||||||||||||||||||||
N/A |
N/A |
N/A |
||||||||||||||||||||||||
CSA Schedule 1 View glossary of CSA terms | ||||||||||||||||||||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||||||||||
Pregnancy Category | ||||||||||||||||||||||||||
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||||||||||||||||||
Drug Interactions | ||||||||||||||||||||||||||
A total of 15 drugs are known to interact with Verkazia:
|
A total of 98 drugs are known to interact with Maxitrol:
|
A total of 74 drugs are known to interact with Diclofenac ophthalmic:
|
||||||||||||||||||||||||
Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||||||||||
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||||||||||
Disease Interactions | ||||||||||||||||||||||||||
No known disease interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||||||||||||
First Approval Date | ||||||||||||||||||||||||||
June 23, 2021 |
July 19, 1963 |
N/A |
||||||||||||||||||||||||
WADA Class View classifications | ||||||||||||||||||||||||||
N/A |
N/A |
|||||||||||||||||||||||||
More Information | ||||||||||||||||||||||||||
Patient Resources | ||||||||||||||||||||||||||
Professional Resources | ||||||||||||||||||||||||||
Related Treatment Guide | ||||||||||||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.